Exploring, Understanding and Applying the Benefits of Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
A Dexcom presentation theater held in conjunction with MEDS Part One Summer Conference. This bonus presentation is independently organized and not an official part of MEDS Summer 2021.
Friday, July 30, 2021
The progressive nature of type 2 diabetes changes diabetes management over time in a variety of ways and is different for each person living with diabetes. Continuous glucose monitoring (CGM) provides a visual context to an individual’s current time-in-range and helps both the person and the healthcare professional identify areas to improve. This presentation will review the limitations of both A1C and blood glucose monitoring while highlighting the benefits of the Dexcom G6 real-time CGM system and Dexcom G6 Professional system in type 2 diabetes management. You will also learn to interpret Dexcom CLARITY reports through patient case studies, and how CLARITY data can be used for diagnostic guidance and therapeutic intervention.
Scott Urquhart, PA-C, DFAAPA
Chair, Metabolic and Endocrine Disease Summit (MEDS) Adjunct Clinical Professor, James Madison University PA program Clinical Instructor, George Washington University PA program Diabetes and Thyroid Associates, Fredericksburg, VA
Jami Klein, RN, BSN, CDCES
Clinical Education, Dexcom